CARGO Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	64.38	405.73	1.87	0.04
Short-Term Investments	275.32	-	-	-
Cash & Short-Term Investments	339.7	405.73	1.87	0.04
Cash Growth	-16.27%	21573.72%	4465.85%	-
Other Receivables	2.04	1.74	0.48	-
Receivables	2.04	1.74	0.48	-
Prepaid Expenses	2.19	1.18	0.15	0.04
Other Current Assets	1.08	0.83	1.43	0.11
Total Current Assets	345.01	409.48	3.93	0.18
Property, Plant & Equipment	34.78	38.6	5.53	3.88
Long-Term Investments	28.39	-	-	-
Other Long-Term Assets	5.88	4.96	0.78	0.44
Total Assets	414.05	453.04	10.24	4.5
Accounts Payable	2.44	5.01	3.48	0.82
Accrued Expenses	20.42	12.63	4.03	0.59
Short-Term Debt	-	-	21.25	-
Current Portion of Leases	0.63	2.28	1.01	0.94
Other Current Liabilities	1.54	1.24	14.36	0.1
Total Current Liabilities	25.03	21.16	44.14	2.45
Long-Term Leases	28.8	26.26	1.09	2.23
Other Long-Term Liabilities	-	0.23	0.25	-
Total Liabilities	53.83	47.65	45.48	4.68
Common Stock	0.05	0.04	0	0.01
Additional Paid-In Capital	672.54	550.49	11.76	5.86
Retained Earnings	-312.65	-145.15	-47	-6.05
Comprehensive Income & Other	0.29	-	-	-
Total Common Equity	360.23	405.39	-35.24	-0.18
Shareholders' Equity	360.23	405.39	-35.24	-0.18
Total Liabilities & Equity	414.05	453.04	10.24	4.5
Total Debt	29.43	28.54	23.35	3.17
Net Cash (Debt)	338.67	377.19	-21.48	-3.13
Net Cash Growth	-10.21%	-	-	-
Net Cash Per Share	7.53	63.51	-54.76	-20.51
Filing Date Shares Outstanding	46.05	39.36	1.09	0.15
Total Common Shares Outstanding	46.04	41.21	1.09	0.15
Working Capital	319.99	388.32	-40.21	-2.27
Book Value Per Share	7.82	9.84	-32.27	-1.19
Tangible Book Value	360.23	405.39	-35.24	-0.18
Tangible Book Value Per Share	7.82	9.84	-32.27	-1.19
Machinery	14.63	10.32	2.79	0.26
Construction In Progress	0.09	1.83	0.89	0.42
Leasehold Improvements	0.87	0.13	0.11	0.02

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q